Angioedema - 88 Studies Found

Completed : Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE
: Hereditary Angioedema
: 2011-10-13
: Drug: Icatibant 30 mg subcutaneous dose of Icatibant
Completed : Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE
: Hereditary Angioedema
: 2013-11-05
:
  • Drug: BCX4161
  • Drug: Placebo
Completed : EASSI - Evaluation of the Safety of Self-Administration With Icatibant
: Hereditary Angioedema
: 2009-10-16
: Drug: Icatibant Single subcutaneous injection of icatibant, 30 mg
Completed : A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
: Hereditary Angioedema
: 2010-02-22
: Biological: CINRYZE C1 esterase inhibitor (human)
Completed : A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase
: Hereditary Angioedema
: 2011-08-25
: Biological: CINRYZE with rHuPH20 Other Names:
  • C1 esterase inhibitor (hu
Completed : The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
:
  • Urticaria
  • Angioedema
  • Hives : 2011-06-01
    :
    • Drug: Vitamin D3 Vitamin D 400
Recruiting : Determination of Specific Biomarkers of Angioneurotic Crisis
: Angioedema
: 2016-06-28
Completed : 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks
:
  • Hereditary Angioedema
  • HAE

: 2014-11-24
:
  • Drug: BCX4161
  • Drug: Placebo
Recruiting : Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population
:
  • Hereditary Angioedema
  • Healthy Volunteers

: 2016-07-18
: Other: blood sample
Recruiting : Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
: Hereditary Angioedema (HAE)
: 2009-12-17
<<< Previous | Next >>>